Unified Patent Court (UPC) analytics are now available. Check here

Get Patent Opposition Report for Grnenthal

Comprehensive Analysis, Strategic Insights & Expert Evaluation – Stay Ahead in Your Patent Challenge.

Download Your Report Now

Explore Grnenthal's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Patent NumberGrant DateTitleTotal Oppositions
EP3995135Jul 13, 2022Prolonged Release Dosage Form Of Tapentadol L-(+)- Tartaric Acid Salt2
EP3210965Nov 17, 2021Process For The Preparation Of (1R,2R)-3-(3-Dimethylamino-1-Ethyl-2-Methyl-Propyl)-Phenol3
EP3656765Apr 14, 2021Salts Or Co-Crystals Of 3-(3-Dimethylamino-1-Ethyl-2-Methyl-Propyl)-Phenol6
EP3241550Jul 22, 2020(1R, 2R)-3-(Dimenthyl Amino-1-Ethyl-2-Methyl-Propyl) Phenol For Treating Painful Inflammations4
EP3287123Apr 22, 2020Aqueous Pharmaceutical Formulation Of Tapentadol For Oral Administration1
EP2694050Oct 2, 2019Tapentadol For Treating Pain Associated With Trigeminal Neuralgia1
EP2694049Oct 31, 2018Tapentadol For Preventing Chronification Of Pain3
EP1845956Mar 22, 2017Break-Resistant Delayed-Release Forms Of Administration1